Literature DB >> 8496921

Synthesis and amnesia-reversal activity of a series of 7- and 5-membered 3-acylamino lactams.

L Angelucci1, P Calvisi, R Catini, U Cosentino, R Cozzolino, P De Witt, O Ghirardi, F Giannessi, A Giuliani, D Guaraldi.   

Abstract

A series of 3-(acylamino)-epsilon-caprolactams and 3-(acylamino)-2-pyrrolidinones was synthesized. Some of these compounds reversed at different degrees electroconvulsive shock- and Scopolamine-induced amnesia, using a step-through passive avoidance in mice. Classical nootropic drugs, i.e., Aniracetam, Oxiracetam, and Piracetam, were used as reference compounds. Within the analyses of data performed, we introduced a new parameter, the confrontation index (CI), which is a function of Mann-Whitney's U statistic. The CI permits a common scale of activity of substances to be generated, independently of probabilistic hypotheses, with higher scores representing higher activities. The most active compounds were characterized by the formylamino and [3-(trifluoromethyl)benzoyl]amino groups in the 3-position of the ring. None of the substances assayed showed any effect on spontaneous behavior and neurovegetative system.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496921     DOI: 10.1021/jm00063a001

Source DB:  PubMed          Journal:  J Med Chem        ISSN: 0022-2623            Impact factor:   7.446


  2 in total

1.  Furoxans (Oxadiazole-4 N-oxides) with Attenuated Reactivity are Neuroprotective, Cross the Blood Brain Barrier, and Improve Passive Avoidance Memory.

Authors:  Austin Horton; Kevin Nash; Ethel Tackie-Yarboi; Alexander Kostrevski; Adam Novak; Aparna Raghavan; Jatin Tulsulkar; Qasim Alhadidi; Nathan Wamer; Bryn Langenderfer; Kalee Royster; Maxwell Ducharme; Katelyn Hagood; Megan Post; Zahoor A Shah; Isaac T Schiefer
Journal:  J Med Chem       Date:  2018-05-07       Impact factor: 7.446

2.  Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice.

Authors:  Maxime Cazorla; Joël Prémont; Andre Mann; Nicolas Girard; Christoph Kellendonk; Didier Rognan
Journal:  J Clin Invest       Date:  2011-04-18       Impact factor: 14.808

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.